4-Traders Homepage > Shares > NYSE > WATSON PHARM WPI US9426831031

WATSON PHARM (WPI)

Real time Streaming quotes -

Delayed NYSE - 09/03 11:37:14 am
44.37	USD		-1.07%

09/01

WATSON PHARM: Watson to Present at the Morgan Stanley Global Healthcare Unplugg..

08/13

WATSON PHARM: Watson Plans Q4 2010 ella® (ulipristal acetate) Emergency Contrac..

08/05

WATSON PHARM: Watson Q2 Net Revenue Climbs 29 Percent to $875 Million

News

News

Latest news on WATSON PHARM

09/01	Watson to Present at the Morgan Stanley Global Healthcare Unplugged Conference
08/13	Watson Plans Q4 2010 ella® (ulipristal acetate) Emergency Contraceptive Launch
08/05	Watson Q2 Net Revenue Climbs 29 Percent to $875 Million
08/04	Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
08/03	Watson Promotes Robert Stewart to Executive Vice President, Global Operations
07/15	Watson and Itero Enter Worldwide License Agreement on Biologic Development Candi..
07/14	Eden Biodesign Assists Momotaro-Gene, Inc. to Commence Human Clinical Trials Les..
07/12	Watson Confirms Renvela® for Oral Suspension Patent Challenge
07/08	Watson to Host Conference Call and Webcast to Discuss Second Quarter 2010 Earnin..
07/02	Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product Line and Shares ..
07/02	Watson's Generic Prograf® 5 mg Receives FDA Approval
07/01	Watson Launches Generic Exelon®
06/23	Watson Receives Tentative FDA Approval for Fentanyl Buccal Tablets
06/18	Watson to Present at the Wells Fargo Securities 2010 Healthcare Conference
06/08	Watson to Present at the Goldman Sachs 31st Annual Global Healthcare Conference
06/01	Watson Confirms Columbia Laboratories' Filing of Definitive Proxy Relating to Wa..
05/27	Critical Alerts for Cisco, Best Buy, Noble Energy, Watson Pharmaceuticals, and D..
05/25	Watson Confirms Renvela® Patent Challenge
05/24	Watson's Generic VALTREX® 500 mg and 1000 mg Receives FDA Approval
05/19	Watson Launches Generic Version of LIPITOR® in Canada
05/14	Watson to Present at the 2010 Citi Investment Research Global Healthcare Confere..
05/10	Watson Q1 Net Revenue Climbs 28 Percent to $857 Million
05/07	Watson Reaches Settlement with Teva Over Seasonale(R)
05/05	Watson Confirms EVISTA(R) Patent Challenge
05/05	Watson Confirms SIMCOR(R) Patent Challenge
05/03	Watson To Present at Bank Of America/Merrill Lynch 2010 Healthcare Conference
05/03	Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 7th
04/30	Watson Confirms Trilipix(R) Patent Challenge
04/28	Watson Confirms Rapamune(R) Patent Challenge
04/26	Watson Confirms Cenestin(R) Patent Challenge
04/26	Watson Says Appeals Court Affirms Concerta(R) Patent Invalid
04/15	Watson's Generic Toprol XL(R) 100 mg and 200 mg Receives FDA Approval
04/12	Watson to Host Conference Call and Webcast to Discuss First Quarter 2010 Earning..
03/30	BullMarket.com Updates Outlooks on Generic Drugmaker Stocks
03/16	Watson to Present at Barclay's 2010 Global Healthcare Conference
03/15	Watson Receives FDA Approval for Generic Cardizem(R) LA
03/11	FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscu..
03/10	Watson Announces Actos(R) Patent Challenge Settlement
03/08	Watson Confirms Filing of Generic Opana(R) ER Application
03/04	Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRIN..
03/01	Watson Signs Agreement to Divest Equity Interest in ScinoPharm
03/01	Watson Licenses Population Council's Novel Contraceptive Ring
02/26	Watson to Present at CLSA/Asia USA Investor's Forum
02/23	Watson Reports Net Revenue of $786 Million for the Fourth Quarter 2009
02/22	Watson Files FDA Application for Generic Aplenzin(TM) ER
02/02	Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnin..
02/01	Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize No..
01/28	Watson Completes Acquisition of Eden Biodesign
01/21	Watson Provides Overview of Global Operations; Delivers Outlook for Continued Gr..
01/19	/C O R R E C T I O N -- Watson Pharmaceuticals, Inc./

1 2 3 Next

Chart WATSON PHARM

Short term

Mid-term

Long term

Graphique historique des cours de bourse de WATSON PHARM

Full-screen chart

Income Statement Evolution

More Fundamentals

EPS Reviews

More Estimates Reviews

Price share WATSON PHARM (USA), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map

Partner : Translation into French

Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.